Skip to main navigation Skip to search Skip to main content

Role of DNA methylation in cardiovascular disease

  • Ugo Chianese
  • , Chiara Papulino
  • , Wout Megchelenbrink
  • , Lucia Scisciola
  • , Michelangela Barbieri
  • , Giuseppe Paolisso
  • , Lucia Altucci
  • , Rosaria Benedetti

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

This chapter explores on the role of epigenetic pathways in cardiovascular disease, with a particular focus on providing an overview of DNA methylation involvement. The text encompasses the biology and mechanics of DNA methylation process and its significance in the context of cardiovascular disease conditions. Numerous epidemiological studies reported DNA methylation as the principal risk factor that establishes a link between epigenomic components and the development of disease phenotypes. Methylation represents a fundamental step in the evolutionary trajectory of cardiovascular physiology, and this epigenetic alteration holds promise as both a predictive and diagnostic marker. Additionally, considering the potential to modulate epigenetic processes, this chapter underscores and elucidates the current and potential treatment strategies for cardiovascular disease at various stages, ranging from preclinical to clinical phases.

Original languageEnglish
Title of host publicationPharmacoepigenetics
PublisherElsevier
Pages903-918
Number of pages16
ISBN (Electronic)9780443187223
ISBN (Print)9780443187230
DOIs
Publication statusPublished - 1 Jan 2025

Keywords

  • Cardiovascular disease
  • epi-drug
  • epigenetics
  • methylation
  • pharmacology

Fingerprint

Dive into the research topics of 'Role of DNA methylation in cardiovascular disease'. Together they form a unique fingerprint.

Cite this